ClinicalTrials.Veeva

Menu

Improved Oral Bioavailability of Curcumin Incorporated Into Micelles

U

University of Hohenheim

Status and phase

Completed
Early Phase 1

Conditions

Pharmacokinetics of New Curcumin Formulations
Safety of New Curcumin Formulations

Treatments

Dietary Supplement: curcumin

Study type

Interventional

Funder types

Other

Identifiers

NCT01982734
051113-HS2

Details and patient eligibility

About

Curcumin, a lipophilic polyphenol derived from the plant curcuma longa possesses numerous health-promoting activities. The oral bioavailability of curcumin is low due to its poor aqueous solubility, limited gastrointestinal absorption, rapid metabolism and excretion. Therefore, we tested, in a randomized crossover study, simultaneous application of phytochemicals and micellar solubilisation, alone and together, as strategies to enhance the absorption of curcumin into the body. Furthermore, we investigated age and sex differences in curcumin pharmacokinetics.

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers with routine blood chemistry values within the normal ranges
  • Age: 18-35 years or > 60 years

Exclusion criteria

  • overweight (BMI >30 kg/m2)
  • metabolic and endocrine diseases
  • pregnancy
  • lactation
  • drug abuse
  • use of dietary supplements or any form of medication (with the exception of oral contraceptives)
  • smoking
  • frequent alcohol consumption (>20 g ethanol/d)
  • adherence to a restrictive dietary regimen
  • physical activity of more than 5 h/wk

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

23 participants in 4 patient groups

Native curcumin
Active Comparator group
Description:
80 mg curcumin as native powder
Treatment:
Dietary Supplement: curcumin
Native curcumin plus phytochemicals
Experimental group
Description:
80 mg curcumin as native powder plus 80 mg sesamin, 40 mg naringenin, 40 mg ferulic acid and 40 mg xanthohumol
Treatment:
Dietary Supplement: curcumin
Curcumin micelles
Experimental group
Description:
80 mg curcumin incorporated into liquid micelles
Treatment:
Dietary Supplement: curcumin
Curcumin micelles plus phytochemicals
Experimental group
Description:
80 mg curcumin incorporated into liquid micelles plus 80 mg sesamin, 40 mg naringenin, 40 mg ferulic acid, 40 mg xanthohumol incorporated into micelles
Treatment:
Dietary Supplement: curcumin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems